[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-355568-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-355568-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","relative-leukocyte-telomere-length-and-the-risk-of-lung-cancer-progression-in-individuals-with-pulmonary-nodules","Relative Leukocyte Telomere Length and the Risk of Lung Cancer Progression in Individuals With Pulmonary Nodules","","Prospective cohort evidence evaluates whether relative leukocyte telomere length (rLTL) predicts lung cancer progression among individuals with pulmonary nodules, where the LTL–risk relationship has been uncertain. rLTL is measured by quantitative PCR in 1803 participants without prior cancer, and lung cancer incidence and mortality are ascertained via ICD-10 linkage. Cox models adjust for demographic, clinical, and radiological variables, and incremental prediction is tested by AUC, NRI, and IDI across established malignancy risk models.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/relative-leukocyte-telomere-length-and-the-risk-of-lung-cancer-progression-in-individuals-with-pulmonary-nodules/355568/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/relative-leukocyte-telomere-length-and-the-risk-of-lung-cancer-progression-in-individuals-with-pulmonary-nodules/355568.png","ImageObject",300,407,{"name":42,"@type":43},"Quinn Holloway","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-23","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",6,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What was the main goal of the study regarding rLTL and lung cancer?","Question",{"text":63,"@type":64},"To determine whether relative leukocyte telomere length (rLTL) is associated with lung cancer progression risk in individuals with pulmonary nodules, despite prior inconsistent findings.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How was rLTL measured and how were outcomes determined?",{"text":68,"@type":64},"rLTL was measured using quantitative PCR, and lung cancer incidence and mortality were ascertained through linkage with a chronic disease surveillance system using ICD-10 codes.",{"name":70,"@type":61,"acceptedAnswer":71},"What did the study find about the relationship between rLTL and lung cancer risk?",{"text":72,"@type":64},"Longer rLTL was associated with a higher lung cancer risk, and rLTL remained an independent predictor across five lung nodule risk models.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},355568,1790452338,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,105,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},"Technology",50,"technology",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},7,"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},2336474466712,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","Wu et al. BMC Medicine (2026) 24:266 [https://doi.org/10.1186/s12916-026-04788-x](https://doi.org/10.1186/s12916-026-04788-x)  \nBMC Medicine  \n RESEARCH Open Access  \nRelative leukocyte telomere length and the risk of lung cancer progression in individuals with pulmonary nodules  \nYuanyuan Wu1†, Dong Sun2†, Zhiming Zhou2†, Dongji Li1, Yang Gao3, Cheng Shen4, Ying Mei 1*†, Xianbin Ding3*† and Feifei Cheng1*†  \nAbstract  \nBackground The role of leukocyte telomere length (LTL) in predicting lung cancer risk remains controversial, particularly in individuals with pulmonary nodules.  \nMethods We conducted a prospective cohort study of 1803 individuals with pulmonary nodules identified by chest CT, with no prior history of cancer. Relative LTL (rLTL) was measured using quantitative PCR. Lung cancer incidence and mortality were ascertained through linkage with the Chongqing Chronic Disease Surveillance System using ICD-10 code. Associations between rLTL and lung cancer risk were assessed using Cox proportional hazards models, with adjustment for demographic, clinical, and radiological variables. We further evaluated the incremental predictive value of rLTL when added to five established lung nodule malignancy risk models using AUC, NRI, and IDI.  \nResults Patients with longer rLTL had an increased risk of lung cancer (adjusted HR = 7.26 (1 .71–30. 87); P = 0 . 007), compared with those with shorter rLTL. Subgroup analyses suggested stronger associations in younger individuals and women, although interactions were non-significant. rLTL remained an independent predictor across all five lung nodule models (HR range, 1.47–1. 72) . While the improvements in AUC and IDI were modest, NRI was significantly improved in all models (range, 0 .380–0. 847, all P \u003C 0. 05), suggesting better risk reclassification.  \nConclusion In this health check-up cohort of individuals with pulmonary nodules, longer rLTL was independently associated with increased lung cancer risk. Our findings highlight a potentially paradoxical role of telomere biology in lung carcinogenesis and suggest that rLTL may serve as a useful biomarker for malignancy risk stratification in nodule surveillance.  \n\n| †Yuanyuan Wu, Dong Sun and Zhiming Zhou equal contributors (co-first authors) . |\n| --- |\n| †Ying Mei, Xianbin Ding and Feifei Cheng contributed equally to this work. |\n\n*Correspondence:  \nYing Mei [meiying@cqmu.edu.cn](meiying@cqmu.edu.cn)[ ](meiying@cqmu.edu.cn)Xianbin Ding [xianbinding@126.com](xianbinding@126.com)[ ](xianbinding@126.com)Feifei Cheng  \n[feifeicheng@hospital.cqmu.edu.cn](feifeicheng@hospital.cqmu.edu.cn)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2026. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creativecommons.org/licenses/by-nc-nd/4.0/](http://creativecommons.org/licenses/by-nc-nd/4.0/.)[.](http://creativecommons.org/licenses/by-nc-nd/4.0/.)  \nHighlights  \n• In a prospective cohort of 1803 patients with pulmonary nodules, longer relative leukocyte telomere length (rLTL) was significantly ","cbCaih1nBJqGidSK","https://ap.wps.com/l/cbCaih1nBJqGidSK","pdf",893393,13,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusion\n# Keywords\n# Background","[{\"question\":\"What was the main goal of the study regarding rLTL and lung cancer?\",\"answer\":\"To determine whether relative leukocyte telomere length (rLTL) is associated with lung cancer progression risk in individuals with pulmonary nodules, despite prior inconsistent findings.\"},{\"question\":\"How was rLTL measured and how were outcomes determined?\",\"answer\":\"rLTL was measured using quantitative PCR, and lung cancer incidence and mortality were ascertained through linkage with a chronic disease surveillance system using ICD-10 codes.\"},{\"question\":\"What did the study find about the relationship between rLTL and lung cancer risk?\",\"answer\":\"Longer rLTL was associated with a higher lung cancer risk, and rLTL remained an independent predictor across five lung nodule risk models.\"}]","Relative Leukocyte Telomere Length and the Risk of Lung Cancer Progression in Individuals With Pulmonary Nodules | PDF",1790119907,33,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d1cc3d785727523427761308f90c227c.webp",983,1305,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d36a19a4d8c9e7e79799f996d7592cfc.webp",982,1304,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8d61f2448801fa146301bf5992146e9a.webp",981,1303,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/fe02acaf8a6b28b95828c983f0bd62e4.webp",980,1301]